UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
May 10, 2024 4:00 P.M.
Form:
F-3
CIK:
0001962738
Company Name:
CASI Pharmaceuticals, Inc.
File Number:
333-279096